Does FOSAPREPITANT DIMEGLUMINE Cause Gait inability? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Gait inability have been filed in association with FOSAPREPITANT DIMEGLUMINE (Fosaprepitant). This represents 2.7% of all adverse event reports for FOSAPREPITANT DIMEGLUMINE.
24
Reports of Gait inability with FOSAPREPITANT DIMEGLUMINE
2.7%
of all FOSAPREPITANT DIMEGLUMINE reports
23
Deaths
23
Hospitalizations
How Dangerous Is Gait inability From FOSAPREPITANT DIMEGLUMINE?
Of the 24 reports, 23 (95.8%) resulted in death, 23 (95.8%) required hospitalization, and 23 (95.8%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT DIMEGLUMINE. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does FOSAPREPITANT DIMEGLUMINE Cause?
Dyspnoea (142)
Pyrexia (136)
Nausea (130)
Infusion related reaction (83)
Diarrhoea (80)
Vomiting (71)
Rash (66)
Hypersensitivity (65)
Stomatitis (64)
Decreased appetite (62)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which FOSAPREPITANT DIMEGLUMINE Alternatives Have Lower Gait inability Risk?
FOSAPREPITANT DIMEGLUMINE vs FOSCARBIDOPA\FOSLEVODOPA
FOSAPREPITANT DIMEGLUMINE vs FOSCARNET
FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN
FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN TROMETHAMINE
FOSAPREPITANT DIMEGLUMINE vs FOSINOPRIL